TAMPA, Fla. — WellSync said its BoomRx prescription-management platform has surpassed a $70 million annualized run rate in less than a year since launch, underscoring strong demand for technology that helps healthcare providers streamline prescription sourcing and fulfillment.
Launched in July 2025, BoomRx serves as the pharmacy infrastructure platform within WellSync’s broader digital healthcare ecosystem. The company said the platform is now used by more than 4,500 clinics across all 50 states and U.S. territories, processing more than 40,000 orders per month and maintaining a 20% month-over-month growth rate. More than 85% of clinics return to place additional orders through the system.
WellSync said BoomRx helps telemedicine providers, enterprise healthcare organizations, and medical practices simplify prescription management, an area that has grown increasingly complex amid regulatory changes and pharmaceutical supply-chain challenges.
“In light of the evolving regulatory landscape and ongoing pharmaceutical supply-chain issues, we recognized the immediate need among healthcare providers for a single solution that could remove the administrative headaches associated with prescription management,” said Fabian Calvo, CEO of WellSync. “WellSync has continued to invest in the technology, operational infrastructure, and customer-support model behind BoomRx, and that investment is reflected in the platform’s rapid adoption.”
The platform provides centralized access to prescription sourcing and fulfillment services, supporting healthcare providers across medical weight management, hormone therapy, sexual health, longevity, wellness, esthetics, and men’s and women’s healthcare.
According to WellSync, recent enhancements to the BoomRx platform have increased pharmacy production capacity, accelerated order fulfillment and strengthened compliance safeguards. The company also said the platform is designed to help providers address issues such as counterfeit or expired medications, interstate distribution challenges and improper shipping conditions.
“Everything we’re building into the BoomRx platform is targeted toward helping medical clinics operate more efficiently while supporting strong compliance practices and a more reliable patient-care experience,” said Kurt Lunkwitz, co-founder and president of BoomRx.
The company noted that demand for virtual-care infrastructure continues to grow, citing forecasts that the global telehealth market could expand from about $219 billion in 2026 to more than $1.2 trillion by 2034.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
